PENICILLIN G POTASSIUM Drug Patent Profile
When do Penicillin G Potassium patents expire, and when can generic versions of Penicillin G Potassium launch?
Penicillin G Potassium is a drug marketed by Mylan, Purepac Pharm, Acs Dobfar Spa, Apothecon, Consolidated Pharm, Hq Speclt Pharma, Lilly, Parke Davis, Pfizer, Sandoz, Watson Labs Inc, Ivax Sub Teva Pharms, Teva, Wyeth Ayerst, and Baxter Hlthcare. and is included in twenty-one NDAs.
The generic ingredient in PENICILLIN G POTASSIUM is penicillin g potassium. There is one drug master file entry for this compound. Nine suppliers are listed for this compound. Additional details are available on the penicillin g potassium profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Penicillin G Potassium
A generic version of PENICILLIN G POTASSIUM was approved as penicillin g potassium by SANDOZ on August 30th, 2002.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for PENICILLIN G POTASSIUM?
- What are the global sales for PENICILLIN G POTASSIUM?
- What is Average Wholesale Price for PENICILLIN G POTASSIUM?
Summary for PENICILLIN G POTASSIUM
| US Patents: | 0 |
| Applicants: | 15 |
| NDAs: | 21 |
| Finished Product Suppliers / Packagers: | 7 |
| Raw Ingredient (Bulk) Api Vendors: | 89 |
| Clinical Trials: | 4 |
| Patent Applications: | 6,172 |
| Drug Prices: | Drug price information for PENICILLIN G POTASSIUM |
| What excipients (inactive ingredients) are in PENICILLIN G POTASSIUM? | PENICILLIN G POTASSIUM excipients list |
| DailyMed Link: | PENICILLIN G POTASSIUM at DailyMed |
Recent Clinical Trials for PENICILLIN G POTASSIUM
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Haining Health-Coming Biotech Co., Ltd. | Phase 2 |
| Alphacait, LLC | Phase 2 |
| Phillip Brian Smith | Phase 1 |
Pharmacology for PENICILLIN G POTASSIUM
| Drug Class | Penicillin-class Antibacterial |
US Patents and Regulatory Information for PENICILLIN G POTASSIUM
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mylan | PENICILLIN G POTASSIUM | penicillin g potassium | TABLET;ORAL | 060781-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Sandoz | PENICILLIN G POTASSIUM | penicillin g potassium | INJECTABLE;INJECTION | 065079-003 | Aug 30, 2002 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Teva | PENICILLIN G POTASSIUM | penicillin g potassium | TABLET;ORAL | 060306-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Purepac Pharm | PENICILLIN G POTASSIUM | penicillin g potassium | TABLET;ORAL | 061588-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Teva | PENICILLIN G POTASSIUM | penicillin g potassium | TABLET;ORAL | 060306-003 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Baxter Hlthcare | PENICILLIN G POTASSIUM IN PLASTIC CONTAINER | penicillin g potassium | INJECTABLE;INJECTION | 050638-001 | Jun 25, 1990 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
